Difference between revisions of "Part:BBa K2107000:Experience"

(Validation and proof of concept of BBa_K2107000)
Line 1: Line 1:
 
+
<html>
__NOTOC__
+
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
+
how you used this part and how it worked out.
+
  
 
Validation and proof of concept of BBa_K2107000
 
Validation and proof of concept of BBa_K2107000
 +
 +
</br></br>
  
 
1. Construct validation:
 
1. Construct validation:
 
After cloning and transformation we did growth curves using this part. Control groups consisted of the cell chassis alone and cell chassis with inducer. Test  groups consisted of the transformed cell chassis with and without inducer. We saw that the cell transformed cell chassis exhibited a slight fitness cost indicating acceptance of BBa_K2107000. While the transformed cell chassis with inducer exhibited a large fitness cost indicating that the construct is being expressed.
 
After cloning and transformation we did growth curves using this part. Control groups consisted of the cell chassis alone and cell chassis with inducer. Test  groups consisted of the transformed cell chassis with and without inducer. We saw that the cell transformed cell chassis exhibited a slight fitness cost indicating acceptance of BBa_K2107000. While the transformed cell chassis with inducer exhibited a large fitness cost indicating that the construct is being expressed.
 +
 +
<center></br></br><img src="https://static.igem.org/mediawiki/parts/3/31/Lubbock_ttu_pdgf.png" width="50%" height""></img></br><b>Fig 1.</b> Shows that induced origami cells cloned with PDGF-B Iso 1 exhibit the highest fitness cost on proliferation </br>rate when compared to all other groups. This indicates that the expression vector transformed into the origami cells is </br>successfully producing protein. n=3</center></br></br>
  
 
2. Part validation:
 
2. Part validation:
 
After confirmation via growth curve we induced and purified protein using periplasmic extraction and nickel column chromatography. To visualize the possible presence of BBa_K2107000 we performed SDS-PAGE of the purified fraction. The SDS showed bands of protein at the correct locations indicating that BBa_2107000 is being expressed and that the DsbA periplasmic translocation leader sequence works as expected.
 
After confirmation via growth curve we induced and purified protein using periplasmic extraction and nickel column chromatography. To visualize the possible presence of BBa_K2107000 we performed SDS-PAGE of the purified fraction. The SDS showed bands of protein at the correct locations indicating that BBa_2107000 is being expressed and that the DsbA periplasmic translocation leader sequence works as expected.
 +
 +
<center></br></br><img src="https://static.igem.org/mediawiki/parts/2/25/Lubbock_ttu_sds_page_pdgf.jpg" width="50%" height""></img></br><b>Fig 2.</b> SDS after osmotic shock</center></br></br>
  
 
3. Part purification and correct folding via DsbA translocation proof of concept:
 
3. Part purification and correct folding via DsbA translocation proof of concept:
 
Finally, to obtain more definitive conformation that BBa_k2107000 is being produced and correctly folded we purchased PDGF-B specific antibodies from Santa Cruz Biolabs and ran a western blot. To our delight we were able to visualized a band of protein at the correct location when compared to an industry standard western blot of PDGF-B using the same antibody. This indicates that BBa_K2107000 is being expressed and properly folded in the periplasm.
 
Finally, to obtain more definitive conformation that BBa_k2107000 is being produced and correctly folded we purchased PDGF-B specific antibodies from Santa Cruz Biolabs and ran a western blot. To our delight we were able to visualized a band of protein at the correct location when compared to an industry standard western blot of PDGF-B using the same antibody. This indicates that BBa_K2107000 is being expressed and properly folded in the periplasm.
 +
 +
</br></br>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;<img src="https://static.igem.org/mediawiki/parts/a/a5/Lubbock_ttu_western_blot_messy.png" width="" height""></img>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;<img src="https://static.igem.org/mediawiki/parts/4/47/Lubbock_ttu_western_blot_clean.png" width="" height""></img></br><center><b>Fig 3.</b> Western Blot example of PDGF-B from Santa Cruz biotechnology.&emsp;&emsp;&emsp; <b>Fig 4.</b> Western blot of recombinant PDGF-B Iso 1 purified from E. coli </center></br></br>
 +
 +
</html>
  
 
===User Reviews===
 
===User Reviews===

Revision as of 23:46, 30 October 2016

Validation and proof of concept of BBa_K2107000

1. Construct validation: After cloning and transformation we did growth curves using this part. Control groups consisted of the cell chassis alone and cell chassis with inducer. Test groups consisted of the transformed cell chassis with and without inducer. We saw that the cell transformed cell chassis exhibited a slight fitness cost indicating acceptance of BBa_K2107000. While the transformed cell chassis with inducer exhibited a large fitness cost indicating that the construct is being expressed.




Fig 1. Shows that induced origami cells cloned with PDGF-B Iso 1 exhibit the highest fitness cost on proliferation
rate when compared to all other groups. This indicates that the expression vector transformed into the origami cells is
successfully producing protein. n=3


2. Part validation: After confirmation via growth curve we induced and purified protein using periplasmic extraction and nickel column chromatography. To visualize the possible presence of BBa_K2107000 we performed SDS-PAGE of the purified fraction. The SDS showed bands of protein at the correct locations indicating that BBa_2107000 is being expressed and that the DsbA periplasmic translocation leader sequence works as expected.



Fig 2. SDS after osmotic shock


3. Part purification and correct folding via DsbA translocation proof of concept: Finally, to obtain more definitive conformation that BBa_k2107000 is being produced and correctly folded we purchased PDGF-B specific antibodies from Santa Cruz Biolabs and ran a western blot. To our delight we were able to visualized a band of protein at the correct location when compared to an industry standard western blot of PDGF-B using the same antibody. This indicates that BBa_K2107000 is being expressed and properly folded in the periplasm.

                       
Fig 3. Western Blot example of PDGF-B from Santa Cruz biotechnology.    Fig 4. Western blot of recombinant PDGF-B Iso 1 purified from E. coli


User Reviews

UNIQ9fddff995c92a197-partinfo-00000001-QINU UNIQ9fddff995c92a197-partinfo-00000002-QINU